Henry RiggsChair of the newly formed ISB Board Development Committee
ISB FORMS WORLD CLASS DEVELOPMENT COMMITTEE TO SUPPORT WORLD CLASS RESEARCH
ISB critically relies on the generosity of individuals, corporations and private foundations.
Their philanthropy provides a margin of fiscal and operational flexibility that distinguishes our work in the pursuit of
P4 Medicine (personalized, predictive, preventive and participatory). A proactive rather than reactive approach to combating
disease, the realization of P4 Medicine will profoundly and positively impact human health around the world. From its
founding, ISB has attracted perceptive, forward looking donors by the breadth and promise of our mission.
To increase our receptiveness to this visionary philanthropy, ISB's board has established
a new development committee. The committee will work with ISB's Development staff to implement a fundraising business plan
that provides wide scope for donor support of the strategic objectives and mission of ISB. Members are committed to identifying
and soliciting funds from individuals who have the vision, means and motivation to advance P4 Medicine. Committee members will
also assist in the planning and coordination of fundraising events and campaigns.
Henry E. Riggs will chair the committee. Riggs brings distinguished credentials to the work
at hand, including service as president of Harvey Mudd College, as the founding president of the Keck Graduate Institute of
Applied Life Sciences, and as vice president for University-wide Development at Stanford University.
Other members of the committee include:
- Bill Bowes, a principal and founder of U.S. Venture Partners in San Francisco;
- Fred Frank, vice chairman and director of Lehman Brothers Inc;
- Roger Perlmutter, M.D., Ph.D., executive vice president for Research and Development at Amgen, Inc., and ISB's Chair of the Board; and
- Lee Hood, president of ISB
RUEDI AEBERSOLD RECEIVES ABRF 2008 AWARD
The Association of Biomolecular Resource Facilities (ABRF) presented ISB Co-founder Ruedi Aebersold, PhD, with its 2008 Award in recognition of his outstanding contribution to the field of protein sciences and proteomics.
Ruedi is truly a global leader in the field of proteomics. Among other advances, his group developed a widely used method for the rapid identification and accurate quantification of cellular proteins. Researchers use "protein profiles" developed with the method to identify cells in different states, such as noncancerous vs. cancerous, and to systematically study how cells respond to external stimuli. These "snapshot" profiles indicate which cells contain abnormal levels of certain proteins. The goal of the work is to develop new diagnostic markers for disease and to develop a more complete understand of the biochemical processes that control cell function.
Reudi received the award at the ABRF national meeting in Salt Lake City on February 11. The Association of Biomolecular Resource Facilities is an international society dedicated to advancing core and research biotechnology laboratories through research, communication and education.
Ruedi is a member of the European Molecular Biology Organization. He is also chair of the board of SystemsX, a consortium of Swiss universities that have teamed up with Federal Institutes of Technology in Zurich and Lausanne to distribute 200 million in Swiss Francs allocated by the Swiss parliament to support a nation-wide systems biology science initiative.
Other awards presented to Aebersold include:
- The 2002 Biemann Medal, presented by the American Society of Mass Spectrometry, recognizes significant achievement in basic or applied mass spectrometry early in an individual's career.
- The 2002 Michael Widmer Award, presented by the Novartis Pharma and the Analytical Division of the Swiss Chemical Society at the HPLC 2002 Congress in Montreal, honors Aebersold's extraordinary and innovative contributions in analytical protein biochemistry and proteomics.
- The 2002 Individual World Technology Award for Biotechnology, presented to innovative individuals who are contributing to the advancement of emerging technologies for the benefit of business and society and who will likely become or remain key players in the technological drama unfolding in coming years.
Individuals, foundations and corporations generously support the work of ISB scientists to bring about medical care that is predictive, preventive, personalized and participatory. Tax deductible gifts may be made to ISB in a variety of ways, including annual gifts that promote daily exploration and research, leadership gifts that provide significant programmatic and equipment support, endowment gifts that support scientific creativity and discovery in perpetuity, planned gifts that allow donors to advance the important work of ISB through estate planning, bequests, various types of charitable trusts, as well as other tax-advantaged instruments and gifts of Fellowships and Professorships that support individual scientists working in areas of particular interest to the donor.
For more information, or to discuss your gift, please contact Larry Herron, Vice President for Development, at (206) 732-1211 or .
© 2008 Institute for Systems Biology. All rights reserved.